These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4099381)

  • 21. [On the effect of mucosa-shrinking nose drops].
    Osterwald L
    HNO; 1966 Feb; 14(2):39-41. PubMed ID: 4168347
    [No Abstract]   [Full Text] [Related]  

  • 22. [Imaging time-dependent changes in the nasal mucosa using the most modern morphing software].
    Keerl R; Weber R; Huppmann A; Draf W
    Laryngorhinootologie; 1995 Jul; 74(7):413-8. PubMed ID: 7545399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
    Rüggeberg F
    Z Allgemeinmed; 1974 Apr; 50(11):535-7. PubMed ID: 4135074
    [No Abstract]   [Full Text] [Related]  

  • 24. [Double blind study and cross-over of the effect of nasal lavage with Prorhinel in chronic rhinitis].
    Polasek O; Haudenschild P
    Ther Umsch; 1987 Dec; 44(12):978-81. PubMed ID: 2450408
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the absorption of decongestive nose-drops-investigation with a radioactive labelled imidazoline-derivate (author's transl)].
    Münzel M; Eichner H
    Laryngol Rhinol Otol (Stuttg); 1975 Nov; 54(11):875-88. PubMed ID: 53769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Method for evaluation of action of beta-stimulating and beta-blocking agents on nasal mucous membrane in the rat. A method for investigation of nasal decongestive.
    Stern P; Stern M; Buljubasić S
    Arzneimittelforschung; 1974 Jan; 24(1):70-1. PubMed ID: 4131802
    [No Abstract]   [Full Text] [Related]  

  • 27. [The management of restricted nasal respiration using nasal decongestants. Purposeful and senseless use].
    Rüdiger W
    Med Klin; 1963 Sep; 58(36):1489-91 passim. PubMed ID: 4174555
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sinupret in the treatment of nasal and paranasal sinus diseases].
    Poliakova TS; Vladimirova VV
    Vestn Otorinolaringol; 2001; (2):50-1. PubMed ID: 11338563
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rhinologic agents. 14].
    Furkert K
    Pharm Prax; 1967; 9():255-8. PubMed ID: 4183276
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rhinomanometric tests of the effect of nasivinettes in normal subjects (author's transl)].
    Ey W; Skevas A
    Laryngol Rhinol Otol (Stuttg); 1974 Mar; 53(5):352-7. PubMed ID: 4136431
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of nasal decongestants on the patency of the nose].
    Taniewski M; Walczak W
    Otolaryngol Pol; 1968; 22(5):695-8. PubMed ID: 4179689
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trial of nose drops which counteract swelling in rhinitis. Comparative double blind trial].
    Döderlein K
    Fortschr Med; 1980 Sep; 98(33):1265-7. PubMed ID: 6161868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prothanon eyedrops. 2. Results of clinical test in double-blind experiment].
    Bredemeyer I; Graupner K; Hammer R; Pambor R
    Pharmazie; 1970 Feb; 25(2):118-20. PubMed ID: 4192879
    [No Abstract]   [Full Text] [Related]  

  • 34. Avoidance of postoperative blockage of ventilation tubes.
    Jamal TS
    Laryngoscope; 1995 Aug; 105(8 Pt 1):833-4. PubMed ID: 7543180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of a synthetic prostaglandin and xylometazoline hydrochloride as nasal decongestants.
    Jackson RT; Birnbaum JE
    Otolaryngol Head Neck Surg; 1982; 90(5):595-7. PubMed ID: 6186975
    [No Abstract]   [Full Text] [Related]  

  • 36. Uses and ability of chilies in reducing mucus congestion.
    Akhtar A; Ali MK
    J Pak Med Assoc; 2013 Feb; 63(2):303. PubMed ID: 23894924
    [No Abstract]   [Full Text] [Related]  

  • 37. Objective assessment of nasal airway in children: an evaluation of decongestant therapy.
    Mascia AV
    Ann Allergy; 1968 Sep; 26(9):470-5. PubMed ID: 4176197
    [No Abstract]   [Full Text] [Related]  

  • 38. Physiology and pharmacology of nasal function and mucus secretion.
    Proctor DF; Adams GK
    Pharmacol Ther B; 1976; 2(3):493-509. PubMed ID: 62367
    [No Abstract]   [Full Text] [Related]  

  • 39. Predicting the outcome of submucosal diathermy to the inferior turbinates.
    Jones AS; Wight RG; Kabil Y; Beckingham E
    Clin Otolaryngol Allied Sci; 1989 Feb; 14(1):41-4. PubMed ID: 2465854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of the blood flow of the nasal mucosa by the hydrogen clearance method.
    Tanimoto H; Okuda M; Yagi T; Ohtsuka H
    Rhinology; 1983 Mar; 21(1):59-65. PubMed ID: 6190210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.